Cervical Cancer Prevention: Liquid-Based Cytology and hr-HPV Co-testing Remain the Most Effective Cervical Cancer Screening Method

Insights

In our opinion, the best evidence still supports screening with Pap and hr-HPV together to provide the best protection against cervical cancer for women ages 30 to 65.

Are Longer-term Antibiotics More Effective than Shorter-term Treatment for Lyme disease?

Insights

For some patients infected with Borrelia burgdorferi, symptoms may persist for months or even longer, leading to the question of whether such patients have “chronic Lyme disease,”

Quest and UCSF Pilot Novel Approach to Dementia Screening and Care with Top ACO in NY

Innovation

Primary PartnerCare will pilot a “clinical pathway” designed by Quest Diagnostics and the UCSF Memory and Aging Center.

22q11.2 Deletion Syndrome: Awareness Can Make a Difference

Insights

Prenatal screening for the 22q11.2 deletion is now available by cell-free DNA screening, also known as noninvasive prenatal screening.

Quest Recognized on Disability Equality Index

Our People

We are proud that Quest Diagnostics has been listed on the Disability Equality Index® (DEI), a joint initiative of the American Association of People with Disabilities (AAPD) and the US Business Leadership Network (USBLN), recognizing companies for prioritizing the inclusion of people with disabilities.

What is the APOE gene and how is it related to Alzheimer’s Disease?

Insights

There is currently no proven way to prevent or cure Alzheimer disease. Is there a role for genetic testing to predict risk?

Does Every Patient with a Tick Bite Need a Test for Lyme Disease?

Insights

Important considerations for determining if a Lyme Disease test is necessary include tick identification, geography, symptoms and signs, and duration of tick attachment.

Tick-borne Illnesses: The Risks of a Missed Diagnosis

Insights

Once thought to be required for the diagnosis, it is now clear that up to 30% of patients with Lyme disease never develop a rash.

Load More